Abstract: The present invention relates to nanofiber nonwovens comprising a network of nanofibers, which are composed of at least one nanofiber material and which enclose pores, to methods for producing nanofiber nonwovens, to the use thereof as well as to artificial tissue comprising these nanofiber nonwovens and methods for producing these artificial tissues.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: Electrodes for a bio-impedance measuring device or a body composition monitor, the electrodes being integral with or being attached to a surface of at least one device belonging to a group of electronic and/or non-electronic devices used in the preparation of a dialysis treatment or during dialysis, in particular during peritoneal dialysis, the group preferably consisting of organizers of a continuous ambulatory peritoneal dialysis system (CAPD), automated peritoneal dialysis devices, automated peritoneal dialysis-cyclers (APD-Cycler), bioelectrical impedance analyzers (BIA), body composition monitors (BCM), hand-held electrodes holders for the electrodes, and dialysis apparatuses. Devices and methods used during dialysis are also described.

Abstract: A sensor system of a medical system, in particular a manually operable, gravimetric system for continuous ambulant peritoneal dialysis (CAPD), provides for detection of a treatment status. In particular, the sensor system provides for detection of a phase segment and/or a phase transition during the peritoneal dialysis.

Abstract: Method and device according to the method for determining intracellular and/or extracellular, in particular macromolecular fractions of fluids, preferably of body fluids of living organisms, with the steps: coupling-in a measurement signal through an electrically non-conductive wall into the fluid to be measured; coupling-out an electrical measurement value that is thereby generated in the fluid to be measured; detecting the coupled-out electrical measurement value at a plurality of different frequencies of the electrical measurement signal; determining the intracellular and/or extracellular, in particular macromolecular fractions of the fluid to be measured by means of evaluation of the detected electrical measurement value at a plurality of frequencies of the measurement signal.

Abstract: The invention is directed to a sensor system of a medial system, in particular a manually operable, gravimetric system for continuous ambulant peritoneal dialysis (CAPD) for detection of a treatment status, in particular for detection of a phase segment and/or a phase transition in peritoneal dialysis.

Abstract: Electrodes for a bio-impedance measuring device or a body composition monitor, the electrodes being integral with or being attached to a surface of at least one device belonging to a group of electronic and/or non-electronic devices used in the preparation of a dialysis treatment or during dialysis, in particular during peritoneal dialysis, the group preferably consisting of organizers of a continuous ambulatory peritoneal dialysis system (CAPD), automated peritoneal dialysis devices, automated peritoneal dialysis-cyclers (APD-Cycler), bioelectrical impedance analyzers (BIA), body composition monitors (BCM), hand-held electrodes holders for the electrodes, and dialysis apparatuses. Devices and methods used during dialysis are also described.

Abstract: Method and device according to the method for determining intracellular and/or extracellular, in particular macromolecular fractions of fluids, preferably of body fluids of living organisms, with the steps: coupling-in a measurement signal through an electrically non-conductive wall into the fluid to be measured; coupling-out an electrical measurement value that is thereby generated in the fluid to be measured; detecting the coupled-out electrical measurement value at a plurality of different frequencies of the electrical measurement signal; determining the intracellular and/or extracellular, in particular macromolecular fractions of the fluid to be measured by means of evaluation of the detected electrical measurement value at a plurality of frequencies of the measurement signal.

Abstract: The present invention relates to a device for creating a vascular access for extracorporeal blood treatment including an electrically conductive puncture needle with a proximal endpiece, a distal endpiece, and a base body made of electrically non-conductive material into which the distal endpiece is inserted. In a properly arranged vascular access, the base body, including an electrically conductive contact element, lies on the skin of the patient, when the puncture needle is located within the vessel of the patient. A disconnection or dislocation is detected by the impedance between the electrically conductive puncture needle and the electrically conductive contact element being measured and compared to a limit value. If the impedance measured is within predetermined limits, this indicates a properly arranged vascular access. A disconnection or dislocation of the puncture needle leads to a strong variation in the impedance.

Abstract: The present invention relates to a device for creating a vascular access for extracorporeal blood treatment using an extracorporeal blood treatment device, wherein the device for creating the vascular access has an electrically conductive puncture needle with a proximal endpiece and distal endpiece, and a base body that is made of electrically non-conductive material and into which the distal endpiece of the puncture needle is inserted. In the case of a properly arranged vascular access, the base body, which includes an electrically conductive contact element, lies on the skin of the patient, when the puncture needle is located within the vessel of the patient. A disconnection or dislocation is detected by the impedance between the electrically conductive puncture needle and the electrically conductive contact element being measured and compared to a limit value. If the impedance measured is within predetermined limits, this indicates a properly arranged vascular access.